Tempest Therapeutics Inc (TPST) Annual Balance Sheets

Annual · GAAP · USD millions
Access TPST quarterly Balance Sheets →
Reviewing balance sheet figures over time helps illustrate how Tempest Therapeutics Inc manages its resources, obligations, and shareholder equity.
Annual Report, GAAP in USD millions
ITEM
(Dec 31 2025)
(Dec 31 2024) (Dec 31 2023) (Dec 31 2022) (Dec 31 2021)
Assets
Cash & cash equivalent7.71
Cash & Short-term Investments7.00
Insurance Settlements Receivable0.00
Prepaid Expense And Other Assets Current0.56
Total Current Assets8.27
Equipment/Property/Plant Net0.61
Other Assets, Noncurrent8.06
Operating Lease Right Of Use Asset7.54
Total Assets16.93
Liabilities
Accounts Payable, Current AC1.04
Accrued Liabilities, Current1.08
Estimated Litigation Liability, Current0.00
Long-term Debt, Current Maturities LO0.00
Other Liabilities, Current0.00
Total Current Liabilities3.31
Long-term debt0.00
Total Long-term Debt0.00
Other liabilities, Noncurrent0.00
Operating Lease Liability Current1.19
Operating Lease Liability Noncurrent6.95
Total Liabilities10.26
Stockholders' Equity
Common Stock Value0.01
Additional Paid In Capital Common Stock240.03
Retained Earnings / Accumulated Deficit-233.37
Other Equity0.00
Common Stockholder's Equity6.67
Total Stockholder's Equity6.67
Liabilities & Stockholder's Equity16.93
4 historic quarters locked

Sign in to unlock the full Tempest Therapeutics Inc balance sheet history.

About Tempest Therapeutics Inc Annual Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-K filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001193125-26-130490

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.